LEUKOTRIENES AND THE BLOOD-BRAIN BARRIER
LEUKOTRIENES AND THE BLOOD-BRAIN BARRIER
批准号:
6112290
负责人:
Keith L. Black
金额:
$0.0万
依托单位国家:
美国
项目类别:
财政年份:
1998
资助国家:
美国
项目状态:
已结题
起止时间:
1998-07-01 至 2000-06-30
关键词:
acivicin astrocytes autoradiography blood brain barrier bradykinin brain edema brain neoplasms capillary cytokine receptors eicosanoid metabolism glioma histamine human tissue in situ hybridization laboratory rat leukotrienes lipoxygenase peptidyl dipeptidase protein glutamine gamma glutamyltransferase receptor binding vascular endothelium permeability
中文摘要
LTC4在人脑肿瘤中的表达与其含量有关
肿瘤周围的水肿症。人脑肿瘤表达花生四烯酸5-
脂氧合酶mRNA和5-脂氧合酶的抑制作用将降低
肿瘤中血脑屏障(BBB)的通透性。白三烯(LT)C4
将选择性地打开肿瘤中的血肿瘤屏障(BTB)两倍
而不会增加正常大脑的渗透率。在…的基础上
这些发现表明,白三烯可能允许
增加了抗肿瘤药物对肿瘤组织的输送。相反,
抑制5-脂氧合酶可减轻脑瘤水肿。至
进一步研究白三烯和酶BBB的概念:1A)
脑瘤大鼠脑血流量和血流量的变化
颈动脉(IC)注射白三烯后的体积将被量化;
和1B)将使用电子显微镜来确定
LT增加血脑屏障通透性的机制是通过紧闭
连接或增加胞饮转运。2a)识别另一个
“酶屏障”中可能存在的酶,二肽酶的抗血清(
将LTD4转化为LTE4的酶)用于确定
二肽酶存在于大鼠和人脑毛细血管中,如果是这样的话,
无论是在脑瘤还是脑缺血中丢失。2b)对
酸性蛋白对LTC4的GGTP抑制作用
开张情况将另行决定。进一步理解“酶的作用”
屏障,3A)其他血管活性化合物,缓激肽和组胺,
也可以允许选择性的BBB打开将单独和在
与白三烯联合,有或没有组胺H1和H2
受体阻滞剂和5-脂氧合酶抑制剂。3B)这些措施的影响
将测定化合物对脑血容量的影响。3C)电子
显微镜也将被用来确定增加的机制
渗透性。3D)通过这些将BBB打开到不同大小的分子
化合物将被测定。4)5-脂氧合酶转录本将
进一步表现为人脑肿瘤的特点。5)研究将确定
实验性肿瘤治疗后对药物的通透性是否增加
颈动脉内输注白三烯和其他血管活性化合物。
英文摘要
There is a correlation between LTC4 in human brain tumors and the amount
of edema surrounding tumors. Human brain tumors express arachidonate 5-
lipoxygenase mRNA and the inhibition of 5-lipoxygenase will decrease
blood-brain barrier (BBB) permeability in tumors. Leukotriene (LT) C4
will selectively open the blood-tumor barrier (BTB) in tumors two-fold
without increasing permeability in the normal brain. On the basis of
these findings we have suggested that leukotrienes could allow for
increased delivery of anti-tumor drugs to tumor tissue. Conversely,
inhibition of 5-lipoxygenase could reduce brain tumor edema. To
investigate further leukotrienes and the concept of an enzymatic BBB: 1A)
in rats with brain tumors, changes in cerebral blood flow and blood
volume after intracarotid (IC) leukotriene infusions will be quantitated;
and 1B) electron microscopy will be used to determine whether the
mechanism by which LT's increase BBB permeability, is by opening tight
junctions or increasing pinocytic transport. 2A) To identify another
possible enzyme in the "enzymatic barrier," antiserum to dipeptidase (the
enzyme that converts LTD4 to LTE4) is used to determine whether
dipeptidase is present in rat and human brain capillaries, and if so,
whether it is lost in brain tumors or ischemia. 2B) The dose response to
gamma glutamyl transpeptidase (gGTP) inhibition by acivicin to LTC4
opening will be determined. To further understand the "enzymatic
barrier," 3A) other vasoactive compounds, bradykinin and histamine, that
may also allow selective BBB opening will be infused IC alone and in
combination with leukotrienes, with and without histamine H1 and H2
receptor blockers and 5-lipoxygenase inhibitors. 3B) The effect of these
compounds on cerebral blood volume will be determined. 3C) Electron
microscopy will also be utilized to determine the mechanism of increased
permeability. 3D) Opening of the BBB to different size molecules by these
compounds will be determined. 4) 5-lipoxygenase transcripts will be
further characterized in human brain tumors. 5) Studies will determine
whether permeability to drugs is increased in experimental tumors after
intracarotid infusion of leukotrienes and other vasoactive compounds.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Enhanced Drug Delivery to Metastatic Brain Tumors
-
批准号:7076138
-
项目类别:
-
资助金额:$32.48万
-
财政年份:2003
-
负责人:Keith L. Black
-
依托单位:
Enhanced Drug Delivery to Metastatic Brain Tumors
-
批准号:6906443
-
项目类别:
-
资助金额:$32.7万
-
财政年份:2003
-
负责人:Keith L. Black
-
依托单位:
Enhanced Drug Delivery to Metastatic Brain Tumors
-
批准号:6670350
-
项目类别:
-
资助金额:$32.7万
-
财政年份:2003
-
负责人:Keith L. Black
-
依托单位:
Enhanced Drug Delivery to Metastatic Brain Tumors
-
批准号:7073964
-
项目类别:
-
资助金额:$0.56万
-
财政年份:2003
-
负责人:Keith L. Black
-
依托单位:
Enhanced Drug Delivery to Metastatic Brain Tumors
-
批准号:6766711
-
项目类别:
-
资助金额:$32.7万
-
财政年份:2003
-
负责人:Keith L. Black
-
依托单位:
PHASE I STUDY TO ASSESS EFFICACY OF MHC CLASS I PEPTIDE PULSED DENDRI
-
批准号:6416288
-
项目类别:
-
资助金额:$23.8万
-
财政年份:2000
-
负责人:Keith L. Black
-
依托单位:
PHASE I STUDY TO ASSESS EFFICACY OF MHC CLASS I PEPTIDE PULSED DENDRI
-
批准号:6306575
-
项目类别:
-
资助金额:$0.1万
-
财政年份:1999
-
负责人:Keith L. Black
-
依托单位:
LEUKOTRIENES AND THE BLOOD-BRAIN BARRIER
-
批准号:6217917
-
项目类别:
-
资助金额:$16.89万
-
财政年份:1998
-
负责人:Keith L. Black
-
依托单位:
PHASE I STUDY TO ASSESS EFFICACY OF MHC CLASS I PEPTIDE PULSED DENDRI
-
批准号:6264870
-
项目类别:
-
资助金额:$0.1万
-
财政年份:1998
-
负责人:Keith L. Black
-
依托单位:
LEUKOTRIENES AND THE BLOOD-BRAIN BARRIER
-
批准号:6243623
-
项目类别:
-
资助金额:$17.18万
-
财政年份:1997
-
负责人:Keith L. Black
-
依托单位:
BIOCHEMICAL CONTROL OF BBB IN ABNORMAL BRAIN CAPILLARIES
-
批准号:6199738
-
项目类别:
-
资助金额:$38.25万
-
财政年份:1993
-
负责人:Keith L. Black
-
依托单位:
BIOLOGY OF BRAIN TUMORS
-
批准号:2100829
-
项目类别:
-
资助金额:$7.63万
-
财政年份:1993
-
负责人:Keith L. Black
-
依托单位:
BIOCHEMICAL CONTROL OF BBB IN ABNORMAL BRAIN CAPILLARIES
-
批准号:6943079
-
项目类别:
-
资助金额:$38.25万
-
财政年份:1993
-
负责人:Keith L. Black
-
依托单位:
BIOCHEMICAL CONTROL OF BBB IN ABNORMAL BRAIN CAPILLARIES
-
批准号:7086128
-
项目类别:
-
资助金额:$37.35万
-
财政年份:1993
-
负责人:Keith L. Black
-
依托单位:
LEUKOTRIENES AND THE BLOOD-BRAIN BARRIER
-
批准号:2270085
-
项目类别:
-
资助金额:$8.56万
-
财政年份:1993
-
负责人:Keith L. Black
-
依托单位:
LEUKOTRIENES AND THE BLOOD-BRAIN BARRIER
-
批准号:3418994
-
项目类别:
-
资助金额:$22.9万
-
财政年份:1993
-
负责人:Keith L. Black
-
依托单位:
LEUKOTRIENES AND THE BLOOD-BRAIN BARRIER
-
批准号:2709236
-
项目类别:
-
资助金额:$7.63万
-
财政年份:1993
-
负责人:Keith L. Black
-
依托单位:
BIOLOGY OF BRAIN TUMORS
-
批准号:3100597
-
项目类别:
-
资助金额:$7.5万
-
财政年份:1993
-
负责人:Keith L. Black
-
依托单位:
BIOLOGY OF BRAIN TUMORS
-
批准号:2100830
-
项目类别:
-
资助金额:$7.93万
-
财政年份:1993
-
负责人:Keith L. Black
-
依托单位:
BIOCHEMICAL CONTROL OF BBB IN ABNORMAL BRAIN CAPILLARIES
-
批准号:6539768
-
项目类别:
-
资助金额:$38.25万
-
财政年份:1993
-
负责人:Keith L. Black
-
依托单位:
国内基金
海外基金
Ascl1介导Wnt/beta-catenin通路在TLE海马硬化中反应性Astrocytes异常增生的作用及调控机制
-
批准号:31760279
-
项目类别:地区科学基金项目
-
资助金额:35.0万元
-
批准年份:2017
-
负责人:丁银秀
-
依托单位: